Creating a new level of R&D confidence
To reach the next phase — and the phase after that — with confidence, it helps to have the kind of tools and product detail you can only get with the deep data of IQVIA.
Our easy-to-access information can help you spot future threats to your portfolio while you still have time to act, and constantly identify new opportunities for licensing or partnerships. You can:
- Access over 470,000 products and nearly 40,000 drug profiles to analyze successful launch strategies.
- Evaluate the progress of your R&D pipeline, gain insights into R&D activities across the industry, monitor therapy class and indication pipelines.
- Review launch activity by indication and therapeutic area, verify market penetration of generics, and monitor the entry of biotechnology drugs.
- Navigate pipeline and product launch data instantly.
Find out how IQVIA unparalleled data assets can be customized to help improve your R&D.
By: Aparna Lanka